{"id":5137,"date":"2022-03-08T11:53:29","date_gmt":"2022-03-08T10:53:29","guid":{"rendered":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/?p=5137"},"modified":"2022-03-08T13:16:32","modified_gmt":"2022-03-08T12:16:32","slug":"8-marzo-2022","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/8-marzo-2022\/","title":{"rendered":"8 marzo, d\u00eda internacional de la mujer."},"content":{"rendered":"\n

Este a\u00f1o el 8 de Marzo de 2022 hemos querido enfocarlo en dos aspectos:<\/p>\n\n\n\n

El acoso laboral dentro del trabajo, en el que explicamos tipos de acoso y que se entiende por acoso.<\/p>\n\n\n\n

Internamente ya comunicamos con anterioridad que existe un protocolo para la prevenci\u00f3n del acoso, est\u00e1 colgado en towanet para vuestra informaci\u00f3n.<\/p>\n\n\n\n

Adjuntamos un art\u00edculo para la lectura.<\/p>\n\n\n\n

\"Acoso<\/figure><\/div>\n\n\n\n
\"Acoso<\/figure><\/div>\n\n\n\n

Segundo aspecto: Concienciaci\u00f3n de utilizar un lenguaje neutro e inclusivo, el objetivo es dar a conocer la relevancia de la presencia de los dos sexos.<\/p>\n\n\n\n

\"Androentrisom\"<\/figure><\/div>\n\n\n\n
\"Ejemplos\"<\/figure><\/div>\n\n\n\n

Os esperamos en el stand de CCOO !!<\/p>\n\n\n\n

\"Gafas<\/figure>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

\n\n\n\n

Puedes consultar este y otros comunicados en la APP de CCOO Towa. Puedes descargar la APP desde este enlace.<\/a><\/strong><\/p>\n\n\n\n

\"800px<\/figure><\/div>\n\n\n\n

#CCOOTOWA: TU DELEGAD@ DE PROXIMIDAD<\/strong><\/em><\/p>\n\n\n\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Este a\u00f1o el 8 de Marzo de 2022 hemos querido enfocarlo en dos aspectos: El acoso laboral dentro del trabajo, en el que explicamos tipos de acoso y que se … Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":5146,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,1,25,26,32],"tags":[],"class_list":["post-5137","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-towa-pharmaceutical-europe-app-push","category-blog","category-notesinformatives","category-notesinformatives_ca","category-prueba","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/5137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=5137"}],"version-history":[{"count":5,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/5137\/revisions"}],"predecessor-version":[{"id":5153,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/5137\/revisions\/5153"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/5146"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=5137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=5137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=5137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}